Here are four points:
1. By 2024, the market is anticipated to reach $9.9 billion.
2. Both governmental and non-governmental organization initiatives aimed at raising awareness on safe drug delivery are spurring market growth.
3. Last year, North America led the market due to a high approval rate of injectable drugs.
4. Market players include:
• Braun Medical in Bethlehem, Pa.
• Fresenius Kabi in Bad Homburg vor der Höhe, Germany
• Baxter International in Deerfield, Ill.
• Terumo Corp. in Tokyo, Japan
• Novo Nordisk in Bagsværd, Denmark
• Covidien in Dublin, Ireland
• Retractable Technologies in Little Elm, Texas
• Becton, Dickinson and Co. in Franklin Lakes, N.J.
More articles on quality & infection control:
Study: ’32k fewer patients would die every year if male physicians could achieve the same outcomes as female physicians’
Medical devices at risk of denial-of-service attacks — 5 insights
3 new studies reveal various types of brain damage in Zika-infected babies: 4 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
